4.8 Review

Nanotechnology applied to overcome tumor drug resistance

期刊

JOURNAL OF CONTROLLED RELEASE
卷 162, 期 1, 页码 45-55

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2012.05.051

关键词

Emerging multidrug resistance; Nanotechnology; Drug delivery system; Chemotherapy; Tumor

资金

  1. Natural Science Foundation of China (NSFC) [30801444]
  2. Natural Science Foundation of Hebei Province [C2009000693, H2012208020]
  3. Hebei University of Science and Technology Discipline Construction Office
  4. State Key Laboratory Breeding Base-Hebei Key Laboratory of Molecular Chemistry For Drug

向作者/读者索取更多资源

Emerging multidrug resistance (MDR) to chemotherapy is amajor obstacle in successfully treatingmalignant diseases. Nanotechnology provides an innovative and promising alternative strategy compared to conventional small molecule chemotherapeutics to circumvent MDR. This review focuses on recent literature examples of nanotechnology applications to overcome MDR. The advantages and limitations of various nanotechnologies are discussed as well as possible approaches to overcome the limitations. Developing a practical nanotechnology-based drug delivery system requires further studies of the tumor microenvironment, the mechanisms of MDR to chemotherapy, the optimal dosage regimen of anticancer drugs and/or siRNA, the transport kinetics of nanocarriers in tumor stroma and the pharmacokinetics of drug-loaded nanocarriers within MDR tumor cells. (C) 2012 Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据